Buscar | Webyourself Social Media Platform

Leena Leena agrega un archivo Other
2024-03-26 14:06:50 -

Advancements in Transthyretin Amyloid Cardiomyopathy: Understanding, Diagnosing, and Treating
Transthyretin amyloid cardiomyopathy (ATTR-CM) is a rare but serious disease caused by the buildup of abnormal deposits of a protein called transthyretin in the heart. These protein deposits interfere with the normal workings of the heart and can lead to heart failure if not treated properly. In this article, we will discuss the causes, symptoms, diagnosis and various treatment options...

0 Commentarios 0 Acciones 1465 Views 0 Vista previa

Please log in to like, share and comment!
Leena Leena agrega un archivo Other
2024-06-25 09:19:31 -

Transthyretin Amyloid Cardiomyopathy Treatment Market Driven by Increasing Prevalence of Cardiomyopathy
The Global Transthyretin Amyloid Cardiomyopathy Treatment Market is estimated to be valued at US$ 1943.69 Bn in 2024 and is expected to exhibit a CAGR of 8.0% over the forecast period 2024 to 2031.Key players operating in the Transthyretin Amyloid Cardiomyopathy Treatment market are DermaSweep Inc., Lifetrons Switzerland AG, Trophy Skin, Silk€TMn, HoMedics USA LLC, PMD Beauty, Dermaglow,...

0 Commentarios 0 Acciones 526 Views 0 Vista previa

Please log in to like, share and comment!
Sneha CMI agrega un archivo Other
2024-02-29 11:38:44 -

Transthyretin Amyloid Cardiomyopathy Treatment Market is driven by Increasing Prevalence of ATTR-CM Disease
The global transthyretin amyloid cardiomyopathy treatment market is primarily driven by the increasing prevalence of ATTR-CM disease globally. Transthyretin amyloid cardiomyopathy, also known as ATTR-CM, is a rare, progressive, and frequently life-threatening heart disease caused by abnormal deposits of amyloid protein consisting of misfolded transthyretin (TTR) in the heart. ATTR-CM treatment...

0 Commentarios 0 Acciones 940 Views 0 Vista previa

Please log in to like, share and comment!